PER-105-06已完成未知
A 52-week, Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder
OVARTIS BIOSCIENSES PERU S.A.,0 个研究点目标入组 0 人开始时间: 2007年1月31日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Written informed consent provided prior to participation in the extension study
- •2. Successful completion of the CLIC477D2303 study.
- •3. Cooperation and willingness to comply with all the requirements of the study.
排除标准
- •1. Premature discontinuation of the CLIC477D2303 study.
- •2. Failure to comply with study CL1C477D2303.
研究者
相似试验
进行中（未招募）
1 期
A 52-week, open-label extension study to evaluate the safety and tolerability of licarbazepine 750-2000 mg/d in the treatment of manic episodes of bipolar I disorder - D2303E1Bipolar I disorder, manic and mixed episodesMedDRA version: 8.1Level: LLTClassification code 10004939Term: Bipolar I disorderEUCTR2004-000687-27-SKovartis Pharma AG215
进行中（未招募）
1 期
An extension study to evaluate the long term safety, tolerability and effectiveness of SEP-4199 CR in patients with major depressive episodes associated with Bipolar I disorder.Major Depressive Episodes Associated with Bipolar I DisorderMedDRA version: 20.0Level: PTClassification code 10004939Term: Bipolar I disorderSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2021-002108-11-HRSunovion Pharmaceuticals Inc.355
进行中（未招募）
1 期
An extension study to evaluate the long term safety, tolerability and effectiveness of SEP-4199 CR in patients with major depressive episodes associated with Bipolar I disorder.Major Depressive Episodes Associated with Bipolar I DisorderMedDRA version: 20.0Level: PTClassification code 10004939Term: Bipolar I disorderSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2021-002108-11-SKSunovion Pharmaceuticals Inc.355
进行中（未招募）
3 期
A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression).JPRN-jRCT2031220302Yabuuchi Kazuki355
进行中（未招募）
1 期
An extension study to evaluate the long term safety, tolerability and effectiveness of SEP-4199 CR in patients with major depressive episodes associated with Bipolar I disorder.Major Depressive Episodes Associated with Bipolar I DisorderMedDRA version: 20.0Level: PTClassification code 10004939Term: Bipolar I disorderSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2021-002108-11-BGSunovion Pharmaceuticals Inc.355